FRANKLIN, Mass., Feb. 10 /PRNewswire/ -- Sontra Medical Corporation
(Nasdaq: SONT) announced today that it will host a conference call and listen-
only Webcast on Thursday, February 17, 2005 at 11:00 a.m. ET to provide a
business update and discuss fourth quarter 2004 financial results.
The conference call is open to all interested parties and will be hosted
by Thomas W. Davison PhD, President and Chief Executive Officer, and Sean
Moran, Chief Financial Officer.
To participate in the live conference call, please dial 973-409-9259.
A listen-only Webcast of the conference call will be available at
http://www.viavid.net/detailpage.aspx?sid=0000202C
About Sontra Medical Corporation (http://www.sontra.com)
Sontra Medical Corporation is a technology leader in transdermal science.
Sontra's SonoPrep ultrasound-mediated skin permeation technology combined with
technical competencies in transdermal drug formulation, delivery systems and
biosensors is creating a new paradigm in transdermal drug delivery and
diagnosis. The SonoPrep technology has demonstrated strong results from
initial human clinical trials at leading universities and medical centers for
several billion market opportunities including the transdermal delivery of
vaccines and large molecule drugs and continuous non-invasive glucose
monitoring. Sontra is currently marketing the SonoPrep device and procedure
tray for use with topical lidocaine to achieve rapid (within five minutes)
skin anesthesia.
Contacts:
Sean Moran
Sontra Medical, CFO
508-553-8850, ext. 234
Evan Smith, CFA
212-850-5606
Erica Pettit
Financial Dynamics
212-850-5614
SOURCE Sontra Medical
 back to top
Related links:
http://www.sontra.com
CONTACT:
Sean Moran, CFO of Sontra Medical,
+1-508-553-8850, ext. 234; or Evan Smith of CFA, +1-212-850-5606;
or Erica Pettit of Financial Dynamics, +1- 212-850-5614
|
